4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Fangzhou Inc. (6086) operates in the Pharmaceutical Retailers industry and is headquartered in Guangzhou, China with about 514 employees. Its market capitalization is roughly HK$1 billion. In the fiscal year ended 2025-12-31, 6086 reported CNY 3.5B in revenue and CNY 12M in net income.
Fangzhou Inc. provides online chronic disease management services in China. It operates through four segments: Online Retail Pharmacy Services; Comprehensive Medical Services; Wholesale; and Customized Content and Marketing Solutions.
Interactive charts & full statements → Open the 6086 valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | CNY 3.5B | CNY 2.7B | CNY 2.4B | CNY 2.2B | — |
| Gross Profit | CNY 559M | CNY 516M | CNY 487M | CNY 381M | — |
| Operating Income (EBIT) | CNY 12M | (CNY 749M) | (CNY 27M) | (CNY 127M) | — |
| Net Income | CNY 12M | (CNY 855M) | (CNY 197M) | (CNY 383M) | — |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | CNY 814M | CNY 664M | CNY 521M | CNY 519M | — |
| Total Liabilities | CNY 660M | CNY 532M | CNY 2.4B | CNY 2.2B | — |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 6086 viewer.
About TickerBase · Data methodology & sources · Privacy · Terms